Zobrazeno 1 - 10
of 10 304
pro vyhledávání: '"Health technology assessment"'
Publikováno v:
Recent Developments in Health Econometrics
Publikováno v:
BMC Health Services Research, Vol 24, Iss 1, Pp 1-15 (2024)
Abstract Background Health technology assessment uses explicit economic evaluation evidence to support health benefits package design. However, the limited availability of technical expertise, data, and methods has restricted the production of econom
Externí odkaz:
https://doaj.org/article/d43bf301c5c044ddb1f02f3823ad56ed
Autor:
Lucas Frederik van Schaik, Ellen Gurumay Engelhardt, Wim Herbert van Harten, Valesca Pavlawna Retèl
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background Comprehensive genomic profiling (CGP) can identify targets beyond standard of care, potentially revolutionizing personalized cancer management. However, conducting well designed studies in this rapidly evolving field is complex an
Externí odkaz:
https://doaj.org/article/dfa775076b254ef5919331a8af7dd92e
Publikováno v:
Health Economics Review, Vol 14, Iss 1, Pp 1-5 (2024)
Abstract Health Technology Assessment (HTA) is essential for evidence-based healthcare decision-making, yet its integration into Iran’s healthcare system faces political and logistical challenges. Despite HTA’s potential to improve resource alloc
Externí odkaz:
https://doaj.org/article/a743a8e77fa54a7da94f88ade1625f54
Autor:
Brian Matovu, Mercy Takuwa, Charles Norman Mpaata, Noah Kiwanuka, Julius Mugaga, Racheal Patricia Nalwoga, Success Kamuhanda, Paula Kworekwa, Benedict Mulindwa, George William Jjuuko, Maria Klara Wolters, Marc P. Y. Desmulliez, Robert T. Ssekitoleko
Publikováno v:
Trials, Vol 25, Iss 1, Pp 1-12 (2024)
Abstract Background Africa, specifically the Sub-Saharan region, has had numerous medical technology clinical trials to address the various healthcare challenges around infectious diseases, non-communicable diseases, and nutritional disorders it is f
Externí odkaz:
https://doaj.org/article/5f54b17652874d989d92038e315ca018
Publikováno v:
Health Research Policy and Systems, Vol 22, Iss 1, Pp 1-13 (2024)
Abstract Background When clinically effective, cost-effective health interventions are not fully implemented in clinical practice, population health suffers. Economic factors are among the most commonly cited reasons for suboptimal implementation. De
Externí odkaz:
https://doaj.org/article/cb2d531e15de4665aa9fc8341c29eb55
Autor:
Al Rashdi, Ibrahim, Al Balushi, Sara, Al Shuaili, Alia, Al Rashdi, Said, Ibrahim Al Bulushi, Nadiya, Ibrahim Al Kindi, Asiya, Al Salmi, Qasem, Al Sabti, Hilal, Korra, Nada, Abaza, Sherif, Fasseeh, Ahmad Nader, Kaló, Zoltán
Publikováno v:
Journal of Health Organization and Management, 2024, Vol. 38, Issue 9, pp. 241-257.
Externí odkaz:
http://www.emeraldinsight.com/doi/10.1108/JHOM-01-2024-0012
Publikováno v:
ClinicoEconomics and Outcomes Research, Vol Volume 16, Pp 581-596 (2024)
Jeffrey M Muir,1 Amruta Radhakrishnan,1 Ipek Ozer Stillman,2 Grammati Sarri3 1RWA Health Economics, Cytel Inc., Toronto, ON, Canada; 2Value, Evidence & Health Economics, Takeda Pharmaceuticals, Lexington, MA, USA; 3RWA Health Economics, Cytel Inc., L
Externí odkaz:
https://doaj.org/article/e256a45184014dfca507c41ce7c236de
Publikováno v:
Health and Quality of Life Outcomes, Vol 22, Iss 1, Pp 1-9 (2024)
Abstract Objectives Estimates of minimally important differences (MID) can assist interpretation of data collected using patient-reported outcomes (PRO), but variability exists in the emphasis placed on MIDs in health technology assessment (HTA) guid
Externí odkaz:
https://doaj.org/article/47c0f90fc7864634acce89062d2fde73
Publikováno v:
Journal of Market Access & Health Policy, Vol 12, Iss 3, Pp 144-157 (2024)
National pricing and reimbursement agencies face growing challenges with complex health technologies, prompting European policy advancements. Beneluxa is a cross-country collaboration involving Belgium, the Netherlands, Luxemburg, Austria, and Irelan
Externí odkaz:
https://doaj.org/article/095fb859f18c4019a284c0368f75b13a